Successful T cell engineering with gene scissors
The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells and have been only been of limited clinical value. Using the new CRISPR-Cas9 gene editing tool, a team at the Technical University of Munich (TUM) has now engineered T cells that are very similar to physiological immune cells.
There are two forms of T cell therapy: either a recipient receives cells from a donor, or the recipient’s own T cells are removed, genetically reprogrammed in a laboratory and unleashed against an infection or tumor in the body. While the first method has proven to be successful in clinical models, reprogramming T cells is still beset with problems.
The team led by Professor Dirk Busch, Director of the Institute for Medical Microbiology, Immunology and Hygiene at the TUM, has generated modified T cells for the first time that are very similar to their natural counterparts and could solve some of those problems. To do so, they utilized the new CRISPR-Cas9 gene scissors, which can be used to snip out and replace targeted segments of the genome.
Both the conventional methods and the new method target the key homing instrument of T cells, known as the T cell receptor. The receptor, residing on the cell’s surface, recognizes specific antigens associated with pathogens or tumor cells, which the T cell is then able to attack. Each receptor is made up of two molecular chains that are linked together. The genetic information for the chains can be genetically modified to produce new receptors that are able to recognize any desired antigen. In this way, it is possible to reprogram T cells.
Targeted exchange using the CRISPR-Cas9 gene scissors
The problem with conventional methods is that the genetic information for the new receptors is randomly inserted into the genome. This means that T cells are produced with both new and old receptors or with receptors having one old and one new chain. As a result, the cells do not function as effectively as physiological T cells and are also controlled differently. Moreover, there is a danger that the mixed chains could trigger dangerous side effects (Graft-versus-Host Disease, GvHD).
“Using the CRISPR method, we’ve been able to completely replace the natural receptors with new ones, because we’re able to insert them into the very same location in the genome. In addition, we’ve replaced the information for both chains so that there are no longer any mixed receptors,” explains Kilian Schober, who is a lead author of the new study along with his colleague Thomas Müller.
Thomas Müller explains the advantages of the modified T cells: “They’re much more similar to physiological T cells, yet they can be changed flexibly. They’re controlled like physiological cells and have the same structure, but are capable of being genetically modified.“ The scientists have demonstrated in a cell culture model that T cells modified in this way behave nearly exactly like their natural counterparts.
“Another advantage is that the new method allows multiple T cells to be modified simultaneously so that they’re able to recognize different targets and can be used in combination. This is especially interesting for cancer therapy, because tumors are highly heterogeneous,” Dirk Busch adds. In the future, the team plans to investigate the new cells and their properties in preclinical mouse models, an important step in preparing for clinical trials with humans.
Learn more: Successful T cell engineering with gene scissors
The Latest on: CRISPR-Cas9 gene scissors
via Google News
The Latest on: CRISPR-Cas9 gene scissors
- Crispr put to the test in first in-body gene editing trialson January 7, 2020 at 3:20 am
FILE — Emily King, a co-op student for virology at Editas Medicine in Cambridge, sets up an experiment to quantify DNA. Editas is among those companies looking to treat patients using Crispr-Cas9 ...
- Crispr puts first human in-body gene editing to teston January 6, 2020 at 8:00 pm
Discovered in 2012, Crispr-Cas9, often shortened to Crispr ... The Crispr genetic code can guide Cas9 — an enzyme that acts like molecular scissors — to specific locations on the genome, allowing ...
- Gene editing breakthroughs that cured genetic diseases in 2019on January 4, 2020 at 3:36 pm
The stem cells were sent to a Scottish laboratory, where their DNA was modified using Crispr/Cas9 – pronounced “Crisper” – a new tool ... explaining that the Crispr “scissors” often cut next to the ...
- Zacks Investment Research Downgrades Intellia Therapeutics (NASDAQ:NTLA) to Holdon January 1, 2020 at 4:09 am
It believes the CRISPR-Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. The Cas9 protein acts ...
- CRISPR genetically modified babies scientist gets three years in jailon December 31, 2019 at 12:02 pm
He reportedly used the CRISPR-cas9 gene-editing tool, which is a wildly powerful piece of technology that basically acts as genetic scissors, letting scientists snip out individual genes. While the ...
- Year in Review: Gene Therapy Technology and a Milestone 2019 for Medical Researchon December 30, 2019 at 1:35 am
While still nascent, gene therapy and the technology of editing genes can be pivotal in curing diseases that have so far been impossible for medical science.
- These biomedical breakthroughs of the decade saved lives and reduced sufferingon December 28, 2019 at 11:31 am
From cell therapies to hepatitis C treatments to HIV prophylaxis, here are some of the most important biomedical advances of the last decade.
- Gene Editing Tool: Repository Analysis And Information For Every Facet Of The Marketon December 16, 2019 at 10:58 pm
On the contrary, potential applications for CRISPR-Cas9 gene therapy in human therapeutics as ... These engineered nucleases, also known as molecular scissors, are the gene editing tools that are used ...
- Scientists use gene editing to disrupt both latent and active herpes virus in human cellson December 12, 2019 at 6:57 am
Specifically, the experiments reveal that the DNA of an actively replicating virus is more exposed to the Cas9 enzyme—the molecular scissors in the CRISPR-Cas9 gene-editing system. This is because ...
- Website access codeon November 18, 2019 at 3:29 pm
CRISPR — formally known as CRISPR-Cas9 — has been touted as an improvement over conventional gene therapy because of its potential ... acts like molecular scissors that can target and snip out ...
via Bing News